Ibrutinib Alternatives Compared
| Ibrutinib Remove Ibrutinib from your drug comparison | Imbruvica Remove Imbruvica from your drug comparison | Rituximab Remove Rituximab from your drug comparison |
|---|
| Ibrutinib Remove Ibrutinib from your drug comparison | Imbruvica ibrutinib Remove Imbruvica from your drug comparison | Rituximab Remove Rituximab from your drug comparison | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Chronic Lymphocytic Leukemia, Waldenström Macroglobulinemia, Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma, Lymphoma, Graft-versus-host disease. ibrutinib may also be used for purposes... View more |
Imbruvica is an oral tablet that may be taken once daily to treat certain types of cancers. It works by inhibiting the enzyme Bruton tyrosine kinase (BTK) which is part of a crucial signaling... View more |
Prescribed for Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Granulomatosis with Polyangiitis, Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Microscopic polyangiitis, Pemphigus... View more |
||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||
Ratings & Reviews |
||||||||||
Drug Class |
||||||||||
Side Effects |
||||||||||
|
Commonly reported side effects include: infection, anemia, neutropenia, thrombocytopenia, bruise, cytopenia. See the full ibrutinib side effects document. |
Common side effects include: infection, anemia, neutropenia, thrombocytopenia, bruise, cytopenia. See the full Imbruvica side effects document. |
See the full rituximab side effects document. |
||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Imbruvica prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Generic Availability |
||||||||||
|
No |
No |
No |
||||||||
Dosage Form(s) Available |
||||||||||
| N/A |
|
N/A | ||||||||
Brand Names |
||||||||||
| Imbruvica |
N/A |
Riabni, Rituxan, Ruxience, Truxima | ||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||
|
6 hours |
6 hours |
59.8 hours |
||||||||
CSA Schedule**View glossary of terms. |
||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category |
||||||||||
|
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||
Drug Interactions |
||||||||||
|
A total of 379 drugs are known to interact with ibrutinib:
|
A total of 379 drugs are known to interact with Imbruvica:
|
A total of 130 drugs are known to interact with rituximab:
|
||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions |
||||||||||
First Approval Date |
||||||||||
|
November 13, 2013 |
November 13, 2013 |
November 26, 1997 |
||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||
|
N/A |
N/A |
N/A |
||||||||
More Information |
||||||||||
Consumer Resources |
||||||||||
Professional Resources |
||||||||||
Related Treatment Guide |
||||||||||
|
||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.